![]() Euroclone Diagnostica Euroclone Diagnostica is a company engaged in the human diagnostic market segment and in particular in the area of molecular biology. | ![]() CeGaT CeGaT is a company providing gene analyses for medical, research, and pharmaceutical applications. | StageZero Life Sciences StageZero Life Sciences is a company that specializes in the early detection of cancer and multiple disease states through whole blood. | |||
Founding Date | Founding Date 2016 | Founding Date 2013 | Founding Date 2009 | Founding Date 2006 | Founding Date 1998 |
Type | Type Private | Type Subsidiary | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Lund, SE HQ | Locations Siziano, IT HQ Milano, IT Pero, IT | Locations Tübingen, DE HQ | Locations Austin, US HQ | Locations Richmond Hill, CA HQ Richmond, US |
Employees | Employees 902% decrease | Employees 4 | Employees 1374% increase | Employees 1282% increase | Employees 40 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) €2.3m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $3.8m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods €2.2m (FY, 2018) | Cost of goods N/A | Cost of goods N/A | Cost of goods $3.1m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit €62.8k (FY, 2018) | Gross profit N/A | Gross profit N/A | Gross profit $657k (FY, 2022) |
Net income | Net income N/A | Net income €31.9k (FY, 2018) | Net income N/A | Net income N/A | Net income ($11.4m) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised $ 5.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 80m | Total funding raised N/A |

Euroclone Diagnostica is a company engaged in the human diagnostic market segment and in particular in the area of molecular biology.
View company
CeGaT is a company providing gene analyses for medical, research, and pharmaceutical applications.
View companyStageZero Life Sciences is a company that specializes in the early detection of cancer and multiple disease states through whole blood.
View company